PredxBio

Access our brand new White Paper here

Menu

Spatial Intelligence Summit

Shaping the Future of Drug Discovery & Development

Hosted by PredxBio

November 5, 2025 | The Assembly, Pittsburgh, PA

Register for the Event

Spatial Intelligence Summit

Shaping the Future of Drug Discovery & Development

Hosted by PredxBio

November 5, 2025 | The Assembly, Pittsburgh, PA

Register for the Event

Powering clinical decisions with tissue intelligence

Powering clinical decisions
with tissue intelligence

Learn More

Bending the survival curve for
immunotherapy cancer patients
with spatially intelligent biology

Bending the survival curve
for immunotherapy
cancer patients
with spatially
intelligent biology

Learn More

WHITEPAPER

Spatially
Intelligent
Platform

Read the Whitepaper

WHITEPAPER

Spatially
Intelligent
Platform

Read the Whitepaper

What if

you could make confident, earlier decisions from tissue data — before trials fail?

PredxBio helps drug development teams identify response-defining tissue patterns with high confidence, enabling better biomarker discovery, smarter patient stratification, and more efficient clinical trial design.

PredxBio applies unbiased spatial analytics and explainable AI to reveal how tissue biology actually functions.

By resolving functional cell states, spatial microenvironments, and cell–cell interactions, our platform uncovers response-driving biology that conventional analyses overlook — enabling explainable, decision-grade biomarkers.

 

PredxBio enables pharma and biotech teams to operationalize tissue intelligence across discovery and development.

From target and biomarker discovery to patient stratification and trial optimization, we help teams move from exploratory tissue analysis to confident, development-ready decisions.

A Decision Platform for Drug Discovery and Clinical Development

Target & Mechanism Discovery
Reveal response-defining tissue biology that informs target selection and mechanism-of-action hypotheses. PredxBio uncovers biologically meaningful spatial patterns that traditional analyses overlook.
Biomarker Strategy & Translational Readiness
Define tissue-based biomarkers that are predictive, explainable, and suitable for translational and clinical development — enabling discovery insights to carry forward into programs.
Patient Stratification & Response Biology
Stratify patient populations based on tissue-level biology linked to therapeutic response, supporting cohort definition and hypothesis-driven trial design without making individual treatment decisions.
Clinical Trial Design & Optimization
Use tissue-informed insights to guide trial strategy, refine inclusion criteria, and support clearer go/no-go decisions — reducing late-stage risk and wasted spend.
Program-Scale Decision Support
Apply consistent, reproducible tissue intelligence across studies and programs to support portfolio-level decisions and enable learning to compound over time.

Accelerated Drug Discovery

Our solutions are the only ones in the market that identify novel cell types, biomarkers & targets leveraging unbiased spatial analytics and explainable AI

Optimized Clinical Trials

Our solutions achieve previously unattainable level of precision in patient stratification for clinical trials

Advanced Companion Diagnostics

Our precision pathology solutions create highly predictive companion diagnostics and prognostics

Personalized Therapeutic Options

Our solutions attain highly personalized adjuvant therapy options for individual patients and provide actionable insights to patient outcomes

Efficient and Accurate Clinical Workflows

Our solutions address the unmet pathology needs by bringing innovations and delivering unparalleled flexibility and ease

Are you making confident development
decisions from tissue data?

Learn how PredxBio helps drug development teams translate complex tissue biology
into decision-grade insights across discovery and clinical programs.

Contact us

Bending the survival curve for
immunotherapy cancer patients
with spatially intelligent biology

Learn More

Subscribe to our Newsletter

* indicates required

Registration

Join us for the Spatial Intelligence Summit. Complimentary and paid registration categories are listed below – hurry, early bird pricing ends on September 30.

We received your request! One of our team members will be in touch as soon as possible.

Submit your Resume

Download Whitepaper

Download Whitepaper

B. Dusty Majumdar, PhD

CHIEF EXECUTIVE OFFICER

Linkedin-in

B. Dusty Majumdar, PhD  is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across oncology, multi-omics, Real-World Evidence (RWE). diagnostic imaging and liquid biopsy platforms leveraging some of the industry’s most advanced AI platforms, genomic and clinical simulations (digital twins), and emerging medical imaging technologies. Dr. Majumdar’s experience includes leading strategy and marketing as the Chief Marketing Officer (CMO) at IBM and multiple commercial and technical leadership roles at GE Healthcare, Exact Sciences and 3M. He has also led the commercial and strategic functions in a range of start-ups in the healthcare/biopharma space over the last few years.  Dr. Majumdar is a widely respected global leader in the healthcare industry and holds a Ph.D. from the University of Texas at Austin and a bachelor’s degree from the Indian Institute of Technology (IIT), Kharagpur.  He has authored several peer-reviewed scientific publications and holds multiple patents.

Joe Camaratta

Sr. VP Business Development

Linkedin-in

Joe Camaratta specializes in medical technology innovation and commercialization, taking products from concept to clinical adoption. He held executive positions for GE Healthcare and Siemens Healthcare and built businesses in medical imaging, cardiology, and oncology. He founded and led two early stage medical technology companies that apply artificial intelligence to improve clinical decision-making.

Joe holds a Master of Science degree in Computer Science from Rutgers University and a Bachelor of Science degree in Computer Science from Drexel University. He currently serves as an advisor to the Entreprenuerial Investing Program of the Crohn’s & Colitis Foundation, and the University Science Center QED Program focused on commercialization of academic innovations

Bruce Campbell, MS

VP Software Engineering

Linkedin-in

Bruce leads the software engineering and quality assurance teams at PredxBio. As the VP of Software Engineering, he is responsible for analytical infrastructure, product development and the commercialization of machine learning, image processing, and computational biology algorithms. Prior to joining PredxBio, Bruce was at IBM and Xylem in global Director of Data Science roles. He has over 20 years of experience in digital pathology algorithms and is highly motivated to deliver care through digital and computational pathology. He has multiple successful FDA 510k device applications, and multiple CLIA certified algorithms deployed in clinical practice.

Bruce holds a BS in Physics and MS in Applied Mathematics from the University of Rochester, an MS in Statistics from North Carolina State University, and is currently pursuing graduate mathematics studies at The Ohio State University. Bruce loves the outdoors. You can find him hiking and rock climbing in Appalachia.